This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Newish Technology (Beijing) Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations in Cancer Treatment by Huangfan Xie
Introduction
Huangfan Xie is a notable inventor based in Beijing, China. He has made significant contributions to the field of medical technology, particularly in cancer treatment. His innovative approach combines various inhibitors to enhance therapeutic outcomes for patients.
Latest Patents
Huangfan Xie holds a patent for a composition aimed at treating cancer. The patent, titled "Composition for treating cancer and use and medicament thereof," focuses on a unique combination of an SGLT1 inhibitor and a VEGFR2 inhibitor. This composition has been found to have a synergistic anti-tumor effect, as SGLT1 interacts with VEGFR2 to promote tumor development and progression. The findings suggest that this innovative composition can be effectively utilized in cancer treatment.
Career Highlights
Huangfan Xie is associated with Newish Technology (Beijing) Co., Ltd., where he continues to work on groundbreaking medical technologies. His research and inventions have the potential to significantly impact cancer therapies and improve patient outcomes.
Collaborations
Huangfan Xie collaborates with notable colleagues, including Zhongjie Sun and Hailong Qi. Their combined expertise contributes to the advancement of innovative solutions in the medical field.
Conclusion
Huangfan Xie's work exemplifies the intersection of innovation and medical technology, particularly in the fight against cancer. His contributions through patents and collaborations highlight the importance of research in developing effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile